EP3193929

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    15.9.2015
  • EP published:
    12.6.2019
  • EP application number:
    15763016.1
  • Max expiry date:
    14.9.2035
  • Title:
    TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

Timeline

Today
15.9.2015EP application
12.6.2019EP Publication

Owner

  • Name:
    Innate Pharma
  • Address:
    117, Avenue de Luminy, 13009, Marseille, FR

Inventor

  • Name:
    ANDRE, Pascale
  • Address:
    Marseille, FR
  • Name:
    BLERY, Mathieu
  • Address:
    Marseille, FR
  • Name:
    PATUREL, Carine
  • Address:
    Marcy l'Etoile, FR
  • Name:
    SOULAS, Caroline
  • Address:
    Marseille, FR
  • Name:
    WAGTMANN, NicolaÏ
  • Address:
    Cassis, FR

Priority

  • Number:
    201462050948 P
  • Date:
    16.9.2014
  • Country:
    US
  • Number:
    201462067642 P
  • Date:
    23.10.2014
  • Country:
    US
  • Number:
    201462083929 P
  • Date:
    25.11.2014
  • Country:
    US
  • Number:
    201462093141 P
  • Date:
    17.12.2014
  • Country:
    US
  • Number:
    201462093124 P
  • Date:
    17.12.2014
  • Country:
    US

Classification

  • Categories:
    A61K 39/395, C07K 16/28, A61P 35/00, A61P 29/00, A61K 39/00, C07K 16/30

Upload documents